|
| 'Chitosan (1) | 1 (1) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-methyl-4-phenyl-1 (1) | 18 β-glycyrrhetic acid (1) | 2 (1) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) | 32 factorial design (1) |
| 3D QSAR (1) | 3D-QSAR (1) | 3’ UTR region (1) |
| 4 - acetamido phenoxy acetyl hydrazide (1) | 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) |
| 5-fluoroindolin-2-one (1) | 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) |
| 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | A. nilotica (1) |
| ABC analysis (3) | ABC-VED matrix (4) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Accuracy. (1) | Accurate (1) | ACE (1) |
| ACE inhibitor (1) | Aceclofenac (1) | Acetazolamide (1) |
| acetic acid induced writhing test (1) | Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) |
| Acid-resistant capsules (1) | Acne (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Actinomycetes (1) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Acupuncture (1) |
| Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) | Acute inß ammation (1) |
| Acute poisoning (1) | Acute toxicity (1) | acyclovir (2) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (3) |
| Adiantum venustum (1) | ADR (2) | ADR management (1) |
| ADRs (1) | Adsorbent (1) | adverse drug events (1) |
| Adverse drug reaction (5) | Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) |
| Adverse drug reaction. (1) | Adverse Drug Reactions (5) | Adverse events (1) |
| Adverse reaction (1) | Aedes aegypti (1) | Aerobic exercise (1) |
| Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (1) |
| Ageratum conyzoides L (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino wistar rats (1) | Alcohol (1) |
| alcoholic extract (1) | ALDEN (1) | Allergic rhinitis (1) |
| Allergy (2) | Alloxan (1) | Alloxan monohydrate (1) |
| Alocasia indica Schott (1) | Aloe vera (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | alternative therapy (1) | Alzheimer's disease (1) |
| Alzheimers disease (1) | Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) |
| Ambroxol hydrochloride (1) | Amides (1) | Amikacin Sulfate (1) |
| Amino acids (1) | amino benzylated Mannich bases (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin sodium (1) |
| Anabolic. (1) | Analgesia (1) | analgesic (8) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analysis in capsules (1) |
| Analysis of variance (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
| and TGF–β (1) | Anemia (1) | Angiogenic growth factors (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthracyclines (1) | Anti aging (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-diabetes mellitus. (1) | Anti-epileptic drugs utilization (1) |
| Anti-HIV (1) | anti-hypertensive agent (1) | Anti-infective (2) |
| Anti-infective agents (1) | anti-inflammation (1) | anti-inflammatory (6) |
| Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (1) | anti-inflammatory activity', (1) |
| anti-inflammatory agent (1) | anti-inß ammatory (3) | Anti-inß ammatory activity (1) |
| Anti-obesity (1) | Anti-oxidant (1) | Anti-parkinsonism activity (1) |
| anti-spasmodic drug (1) | Anti-tumor agent (1) | antiamnesic agents (1) |
| Antianxiety (1) | antibacterial (3) | antibacterial activity (4) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic Resistance (2) |
| Anticancer (3) | Anticancer activity (1) | Anticholinergic (1) |
| Anticoagulant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidiabetic (2) | Antidiabetic activity (2) |
| Antidiabetic agents (1) | antiepileptic agents (1) | Antiepileptic Drugs (2) |
| antifungal (1) | antifungal activity (1) | Antigen (1) |
| antigen protein (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (1) | Antimicrobial (2) | Antimicrobial activities (1) |
| Antimicrobial activity (6) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial resistance (1) | Antimicrobial Stewardship (1) | Antimicrobials (3) |
| Antimosquito (1) | Antimycotic Activity (1) | antinociceptive (1) |
| Antioxidant (14) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (6) |
| antioxidant effect (1) | Antioxidant properties (1) | Antioxidants (5) |
| Antipsychotics (1) | antipyretic (2) | Antispasmodic (1) |
| Antithrombotic (1) | antiulcer (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (1) | antiviral activity (1) |
| Antiviral RNA (1) | Anxiety (2) | APAP (1) |
| APC (1) | Apoptosis (1) | Application to PK profile studies (1) |
| applications (1) | Appropriateness (1) | Aqueous extract (3) |
| AR Caps (1) | ARDS (1) | Area above the blood glucose levels-time curve. (1) |
| area of wound healing (1) | Areca nut (1) | Arginine (1) |
| ART (1) | Artemia salina (1) | Artemisia macrocephala (1) |
| Arteriovenous malformation (AVM) (1) | Arthritis (1) | Ascorbic acid (3) |
| Asenapine (1) | asian developing nations (1) | Aspirin (1) |
| Assay (2) | Asthma (4) | Asymptomatic neurocognitive impairment (1) |
| Ataxia (1) | ATC/DDD (3) | Atorvastatin (4) |
| Atorvastatin calcium (1) | Atorvastatin. (1) | ATP synthase inhibitor (1) |
| ATP- sensitive K+channel (1) | Attitude (6) | Attitude and practice (1) |
| Attitude. (1) | Authors (1) | Authorship issues (1) |
| Autism spectrum disorders (1) | Auto antibody (1) | Autoimmune disorders (1) |
| Autoimmunity (1) | Avicel (1) | Awareness (2) |
| Ayurveda (1) | Azilsartan medoxomil (1) | Bacoside A3 (1) |
| Bacterial isolates (1) | Bacteriological culture (1) | Bacteriostatic (1) |
| Bangladesh (2) | bark (1) | Barleria cristata (1) |
| Barriers (1) | Bauhinia racemosa (1) | Bauhinia variegata (2) |
| Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) | BCS-IV drug (1) |
| Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) | Bedaquiline (1) |
| Belief (1) | benzimidazoles (2) | Benzothiazole analogues (1) |
| Bibliometrics (3) | Bioactive Metabolites (1) | Bioadhesive (1) |
| Bioanalytical method (1) | Bioanalytical method development (1) | Bioassay (1) |
| bioavailability (5) | Biodegradable (1) | Biohazard (1) |
| Biologics (1) | Bioprospecting. (1) | Biosafety Engineering Control (1) |
| Bitter (1) | Black tea extract (1) | Bleeding time (1) |
| Bleomycin (1) | Blonanserin (1) | Blood brain barrier (1) |
| Blood pressure (2) | Bone (1) | Book Review (1) |
| Borg scale (1) | botulinum toxin (1) | Box-Behnken (1) |
| Brahmi vati (1) | Brain (1) | brand name drugs (1) |
| Branded medication (1) | Bratton-Marshall reagent (1) | Breast cancer (4) |
| Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
| Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
| Bromelain (1) | Bromeliaceae (1) | Bromocresol purple (1) |
| Bronchial Asthma (1) | Bryonia laciniosa (1) | Buccal (1) |
| Buccal Patches (1) | budget forecasting (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Business method (1) | Business model (1) |
| Butea monosperma (1) | C934 (1) | Ca2+ channels (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Calcium (1) |
| Calcium channel blocking (1) | calcium channel blocking activity (1) | Calcium oxalate (1) |
| Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
| Camellia sinensis (1) | Camptothecin (1) | Cancer (2) |
| Cancer Chemotherapy (2) | Candida (1) | Candida albicans (1) |
| Capacity (1) | Capsule (1) | capsules (1) |
| carbamazepin (1) | Carbamazepine (2) | carbohydrazide (1) |
| Carbomyl Linkage (1) | carbon tetrachloride (1) | carbonyl compounds (1) |
| Carbopol 940 (1) | Cardiology (1) | Cardioprotective (1) |
| Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
| Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
| catalepsy (2) | CationicGuargum (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | Cefixime (1) |
| ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
| Cellulase (1) | Cemented (1) | Cementless (1) |
| CEN (1) | Centella asiatica (2) | Central composite design (4) |
| Cephalexin (2) | Cerebrovascular Accident (1) | Cervical dentine hypersensitivity (1) |
| CFFF (1) | chalcone (1) | chalcones (1) |
| Characterization (2) | Chemical stability (1) | Chemometrics (2) |
| Chemotherapy (2) | Chewing gum (1) | Children (1) |
| Children Dentistry (1) | Chitosan (6) | Chitosan Acetate. (1) |
| chitosan microspheres (1) | Chitosan-g-HPβCD (1) | Chlorhexidine (2) |
| Chlorohexidine (1) | cholesterol (1) | Cholinesterase inhibitors (1) |
| Chromotropic acid reagent (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cinnamaldehyde (1) | Cinnamomum cassia (1) | Ciprofloxacin (1) |
| Citrus limon (2) | Claims (1) | Clarithromycin (1) |
| Cleistanthin A (2) | cleistanthin B (2) | Cleistanthus Collinus (1) |
| Clinical attachment level (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical pharmacology (1) | Clinical research (1) | Clinical trial (1) |
| Clinical trials (1) | Clinicians (1) | clonidine (2) |
| Clopidogrel (1) | Closed melt (1) | cloxacillin (1) |
| Cluster analysis (1) | CME (1) | Co-crystal (1) |
| Co-Morbidity (1) | co-precipitation method (1) | Co-surfactant (1) |
| Cochlopermum tinctorium (1) | coding system (1) | Cognition (2) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colonic delivery (1) |
| colorimetric assay (1) | Combination tablet (1) | Combination Therapy (1) |
| Comet assay (1) | Common warts (1) | Community Pharmacies (1) |
| comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) | compensation (1) |
| Complementary and alternative medicine (1) | complementary and alternative medicines (1) | complete epithelization (1) |
| Compliance (1) | compound 48/80 (2) | compritol 888 ATO (1) |
| Computer (1) | computer-aided instructions (1) | Computer-aided learning (1) |
| Computerized screening systems (1) | CoMSIA (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | content validity (1) |
| continuing education (1) | Contract research (1) | Contract research organizations (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Cordia obliqua (1) |
| Corneal opacities (1) | Coronally advanced flap (1) | Correlation (2) |
| Cosmetic (1) | Cost avoidance (1) | Cost of illness (1) |
| Cost saving (1) | Cost. (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) | CRC (1) |
| creatinine (1) | Critical Care Unit (CCU) (1) | Critical Thinking (1) |
| cromolyn sodium (1) | Croscarmellose sodium (CCS) (1) | Crospovidone (1) |
| Crospovidone (CP) (1) | Cross carmellose sodium (1) | cross-linking agents (1) |
| Crossandra (1) | Croton zehntneri (2) | Crystallinity (2) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| Cuminosides (1) | Curcuma longa (1) | current indian scenario of drug interactions (1) |
| curriculum development (1) | Cyclooxygenase (1) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytotoxic (1) |
| Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (2) |
| CZE (1) | D&C (1) | D-optimal design (1) |
| Daily Defined Dose (1) | Death Receptors (1) | Decision making (1) |
| Degradation (1) | Delignification (1) | Delirium (1) |
| democratic government (1) | Dengue high fever (1) | Dental caries (2) |
| Dental Caries. (1) | Dental Students (1) | dentistry. (1) |
| Deodorants (1) | Dependence (1) | Depigmentant (1) |
| Depok Primary Health Care (1) | Depression (1) | Design of experiments. (1) |
| desirability function (1) | Desirability index. (1) | Desmodium gangeticum (1) |
| Detorsion (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Diabetes (2) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (9) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diacerein (1) | DiaKure (1) |
| diclofenac (1) | Diclofenac SLN (1) | Diclofenac sodium (1) |
| Dicots (1) | Dicyclomine (1) | differential scanning calorimetry (1) |
| diffuse transmittance (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dip coating (1) |
| Diplotropis ferruginea (1) | direct compression (2) | Direct to consumer advertising (1) |
| Discharge against medical advice (DAMA) (1) | discharge orders (1) | Discrepancies (1) |
| Discriminant analysis (1) | Disease (1) | disintegration (1) |
| disintegration time (1) | Dissolution (4) | dissolution enhancement (1) |
| Dissolution rate (1) | Diuretic (1) | Diuretic activity (2) |
| DMAIC (1) | DNA damage (1) | DNA fragmentation (1) |
| docking (2) | docking. (1) | Doctor (1) |
| Documentation and records (1) | Donepezil hydrochloride (1) | Dopamine (1) |
| Dosage formulation (1) | Dosage regimen (1) | Dose-dependent (1) |
| DOTS plus (1) | Doxycycline (1) | DPPH Assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) | Drug (2) |
| Drug detailing (1) | drug disposal (1) | Drug Hypersensitivity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | drug interactions (1) | Drug product (1) |
| Drug Related Problems (2) | drug release (1) | Drug safety (2) |
| Drug Safety. (1) | Drug utilization (1) | drug utilization study (1) |
| drug-drug interactions (3) | Drug-SLS tablets. (1) | Drugedrug interaction (1) |
| Drugs (1) | drug–drug gliclazide (1) | Drug–drug interaction (1) |
| Dry extract cinnamon (1) | DSPC (1) | Dual Therapy (1) |
| dual-target-directed drugs (1) | Dunaliella salina (1) | Dysphagia (1) |
| e-prescribing (1) | E. coli (1) | EC50 values (1) |
| Economic (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Editorial (22) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | egg albumin microspheres (1) | Elderly (1) |
| Electrochemical (1) | electrolyte release (1) | electrolytes (1) |
| Electroporation (1) | Elevated plus maze (1) | elevated plus maze model (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emotional (1) |
| Emulsification and Solvent Evaporation (1) | emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) |
| Encholirium spectabile (1) | Endocrine disruptor (1) | Endophytes (1) |
| Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) |
| Enicostemma littorale (1) | Entire plant (1) | entrapment efficiency (2) |
| Envenoming (1) | Environmental Factors (1) | eosinophil (1) |
| Epigallocatechin Gallate (1) | Epigenetics (1) | epilepsy (4) |
| erice declaration (1) | Erythrina indica (1) | erythropoietin (1) |
| Escherichia coli (1) | Escitalopram oxalate (1) | esomeprazole (1) |
| Essential hypertension (2) | Essential medicine (1) | essential medicines (1) |
| essential oil (3) | essential oil composition (1) | Essential principles (1) |
| Estimated Glomerular Filtration Rate (1) | Ethanol (1) | ethanolic extracts (1) |
| Ethiopia (2) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | ethyl cellulose (2) | ethylcellulose (1) |
| ethylene glycol (2) | Eucalyptus hybrid (1) | Eucalyptus oil (2) |
| eudragit (1) | Eudragit RL 100 (1) | eudragit S100 (2) |
| Eudragit-L100 (1) | Eudragit® S100 (1) | Eugenol (1) |
| Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) | Ex-vivo permeation (1) |
| Excision wound model (1) | experiences (1) | Exports (1) |
| Extract (1) | Extrapyramidal side-effects (1) | extrinsic stains (1) |
| extrusion (1) | Ezetimibe (2) | Fabaceae (2) |
| factorial design (5) | Factors associated with medication non-adherence (1) | Falcipain-2 (1) |
| Family satisfaction (1) | family therapy (1) | famotidine (2) |
| fast disintegrating tablet (1) | Fast dissolving films (1) | Fast dissolving tablets (1) |
| Fasting serum insulin level (1) | Fat (1) | Fatty acid profile (1) |
| FC reagent (1) | FDA Approval (1) | Fenugreek (1) |
| Ferritin (1) | Ferrous sulfate (1) | Fialuridine', (1) |
| Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) |
| film (1) | film hydration (1) | First permanent molars (1) |
| Fixed drug eruption (1) | Flavonoid (1) | Flavonoid Compounds (1) |
| flavonoids (2) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating drug delivery system (1) |
| floating lag time (1) | fluoroquinoes (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | folkloric use (1) |
| Food drug and cosmetic act (1) | Forced degradation (3) | Forced degradation studies (1) |
| forced swim test (1) | Formulary (1) | Formulary. (1) |
| Formulation (1) | Formulation and development (1) | Fourier transform infra red spectroscopic (1) |
| FPGEE (1) | Fraction (1) | Franz Diffusion Cell (1) |
| free radical scavenger (1) | Free radicals. (1) | Freund’s complete adjuvant (1) |
| Frusemide (1) | Frusemide-induced complications (1) | FTIR (5) |
| Fumes (1) | furosemide (1) | gallic acid (2) |
| Gamma irradiation (1) | Gangrenous (1) | Ganoderma lucidum (1) |
| Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (2) | Garcinia imberti bourd (1) |
| Garcinia indica (1) | Garcinia latissima (1) | gaseous contact (1) |
| gastric treatment (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (1) | Gelatin (1) |
| gemfibrozil (1) | Gender (1) | Gene silencing (1) |
| Generic (2) | generic drugs (1) | Generic medicines (2) |
| Generic name. (1) | Generic substitution (1) | Generics (1) |
| Genetic polymorphisms (1) | genetic Signature (1) | Genotype frequency (1) |
| Gentamicin (3) | gentamicin sulfate (2) | Geriatrics (3) |
| GFAP (1) | Gibb’s reagent (1) | Ginger (1) |
| Gingival hyperplasia (1) | Gingival hypertrophy (1) | gingival pocket (1) |
| Gingival recession (1) | Gingival thickness (1) | glibenclamide (3) |
| gliclazide (2) | Glimepiride (1) | glimepride (1) |
| Glipizide (3) | glitazars (1) | Global education (1) |
| Glucagon (1) | Glucocorticoids (1) | Glucose (1) |
| glucose tolerance test (1) | glutathione (1) | Glycerine (1) |
| Glycine max (1) | Glycosylated hemoglobin A1c (1) | Goal orientation (1) |
| Goldenhar syndrome (1) | good manufacturing practices (1) | Grafting (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (1) | Griseofulvin (1) | GSH (1) |
| guanyl cyclase stimulator (1) | Guest Editorial (1) | Guidelines (1) |
| Gulf cooperation council (1) | Gum and fat fractions (1) | Gymnema Sylvestre (1) |
| GYTS (1) | H+ (1) | H-460 (1) |
| H2 Receptor Antagonist (1) | Haematological (1) | Haemolytic ratio. (1) |
| Hair Growth Activity (1) | Hair Tonic (1) | Hajj (1) |
| haloperidol (1) | hardness (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hazardous drugs (1) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | head twitch (1) | Health benefits (1) |
| Health care profession (1) | Health care. (1) | Health Hazard (1) |
| Health informatics (1) | Health problems (1) | Health Services Accessibility (1) |
| Healthcare (4) | healthcare communication (1) | Healthcare Delivery (1) |
| healthcare expenditure (1) | Healthcare Professionals (1) | healthcare providers (1) |
| Healthy volunteers (1) | hematological toxicity (1) | Hematology (2) |
| Hematoma (1) | hepatoprotective (2) | hepatoprotective activity (3) |
| Hepatotoxicity (1) | HER1 (1) | HER2 (1) |
| HER3 (1) | HER4 (1) | Herbal active ingredients (1) |
| Herbal medications (1) | Herbal medicine (1) | herbal medicines (1) |
| HET-CAM (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| High fat diet (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
| High-density lipoprotein cholesterol (1) | High-fat diet (1) | high-performance liquid chromatography (2) |
| High-throughput screening (1) | Higher education (1) | highly active antiretroviral therapy (1) |
| Highly Cited Papers (1) | Himatanthus drasticus (1) | Hip Arthroplasty (1) |
| Hirsutism (2) | Histocompatibility. (1) | Histopathology (2) |
| HIV (1) | HIV associated dementia. (1) | HIV-associated neurocognitive disorder (1) |
| HL-60 and K-562 (1) | homology modeling (1) | Honeycomb (1) |
| Hordeum vulgare (1) | Hordeum vulgare hull (1) | hospitalized children (1) |
| hospitalized patients (1) | Hospitals (1) | host (1) |
| hot plate (1) | HP-ß Cyclodextrin complexes (1) | HPLC (7) |
| HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) | HPLC. (1) |
| HPMC (1) | HPMC capsules (1) | HPMC K100M (1) |
| HPMC K4M (1) | HPTLC (5) | HRQoL (2) |
| HSV-1 (1) | Human breast cancer cells (1) | human immunodeficiency virus (2) |
| human immunodeÞ ciency virus (1) | Human Papillomavirus (1) | Human plasma (2) |
| human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) |
| Hydroalcoholic (1) | hydrochlorothiazide (1) | Hydrochlorthiazide (1) |
| hydrogel (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose E15 (1) | Hydroxypropyl-β- cyclodextrin (1) |
| Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) | Hyperactive orofacial musculature (1) |
| Hypercholesterolemia (1) | Hypercholestremia (1) | Hyperglycemic (2) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| hypertension (4) | Hypertension( HTN) (1) | Hypertensive’s (1) |
| hypertriglyceridemia (2) | Hyperzincuria (1) | hypoglycemic (1) |
| Hypoglycemic activity (1) | hypolipidemic (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | IBD - Inflammatory Bowel Disease (1) | IC50 (2) |
| ICH (2) | ICH guidelines (1) | ICP22 (US1) gene (1) |
| IL-17 (1) | IL-6 (1) | Illiterate (1) |
| Iloperidone (1) | image analysis (1) | imidazole (1) |
| Immune response (1) | immunocytochemistry (1) | In silico (2) |
| in situ gelation (1) | in vitro (3) | In vitro Penetration Test. (1) |
| In vitro release (1) | In vitro–In vivo (1) | in vivo (1) |
| In-patien (1) | in-vitro dissolution study (1) | inclusion complexes (2) |
| indexed cost (1) | India (7) | India. (1) |
| Indian context (1) | Indian Traditional medicine (1) | Indion 234 (2) |
| Indion resin (1) | indomethacin (2) | Indonesian National Health Insurance (1) |
| Industry (1) | Inequality (1) | infarct size (1) |
| infertility (1) | inflammation (2) | inflammatory bowel disease (2) |
| Information need (1) | Information system (1) | Information Technology Officers (1) |
| Information tool (1) | innovation ecosystems (1) | inß ammation (2) |
| inß ammatory bowel diseases (1) | insulin (3) | Insulin receptor (1) |
| Insulin regimen (1) | insulin resistance (1) | Insulin resistance. (1) |
| insulin use in primary care (1) | Insulinophobia (1) | Integrase inhibitor (1) |
| Integrated Courses (1) | integrated economic analysis (1) | Intellectual Property l (1) |
| Intellectual property rights (1) | intelligent tutoring (1) | Intensive care unit (1) |
| Intensive Care Unit (ICU) (1) | interaction (2) | interferon (1) |
| interleukins (1) | International Collaboration (1) | International HIV dementia scale (IHDS) (1) |
| international organization (1) | international organizations (1) | international trade (1) |
| Internet (1) | interpretation (1) | Intracanal medicament (1) |
| intraocular presuure (1) | Intrauterine Pregnancy (1) | inventory management (3) |
| investigators (1) | Invited Article (2) | ion pair complex (1) |
| ionotropic gelation (1) | iontophoresis (2) | Iraq (1) |
| Iridoid glycoside (1) | Irvingia gabonensis (1) | isatin (3) |
| ischemia (1) | ischemia-reperfusion injury (1) | Ischemic (1) |
| ISO (1) | isoniazid (1) | isonicotinohydrazide (1) |
| isoproterenol (1) | isoxazoline (1) | itopride HCl (1) |
| JNC 8 Guidelines. (1) | Journal (1) | Jurkat (1) |
| K+-ATPase β subunit (1) | K+ATP channel (1) | K-CAPS (1) |
| K562 (1) | Kajjali (1) | KAP (1) |
| KAP study (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kernel powder (1) | Ketorolac (1) |
| Key words: 5-FU (1) | Key words: Esomeprazole (1) | kidney (2) |
| kinetic drug release (1) | Kinetic Modelling (1) | KMnO4 (1) |
| kneading method (1) | kneading technique (1) | knowledge (7) |
| L-Thyroxine (1) | labeling (1) | Laboratory findings. (1) |
| Lactobacilli (1) | Lactobacillus (1) | Lag period (1) |
| Lagenaria siceraria (1) | Lantana camara (1) | Lantana montevidensis (1) |
| Larvacidal (1) | LC/MS/MS (1) | LCMS/MS (1) |
| LC–MS/MS (1) | LDL-C (1) | leaves (4) |
| Leftover medicines, (1) | Leg Length (1) | Leptin (1) |
| Letter to Editor (4) | Letter to the Editor (3) | Letters to the Editor (6) |
| Leucaena leucocephala (1) | Leucas lavandulaefolia (1) | Levocetirizine (1) |
| Licofelone (1) | Ligand-based drug design (1) | Lightening (1) |
| Limb Length (1) | lime fruit (1) | lipid matrix (1) |
| lipid metabolism (1) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | lipid peroxides (1) | lipid profile (1) |
| lipids (1) | lipoic acid (1) | liposome (1) |
| Lippia (1) | lithium toxicity (1) | liver function (1) |
| Liver necrosis (1) | locomotor activity (1) | Low-density lipoprotein cholesterol (1) |
| Lozenges (1) | Luffa echinata (1) | Luminesce (1) |
| Lung (1) | Lung cancer (1) | Lupenoic acid (1) |
| Lycatab C (1) | Macromicroscopy study (2) | Major Contributed Organizations (1) |
| Malaysia (2) | Malaysia. (1) | Malaysian. (1) |
| malondialdehyde (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mast cell (1) | Matrix Tablet (1) | matrix tablets (3) |
| MCF-7 (1) | MDA (1) | MDR-TB (2) |
| mean age (1) | mechanisms (1) | Meclizine HCl (1) |
| Medical (1) | medical costs (1) | Medical device (1) |
| Medical device recalls (1) | medical errors (1) | Medical informatics (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical sales representative (1) |
| Medical students (2) | medication adherence (3) | medication adherence behaviour (1) |
| medication error (1) | Medication errors (1) | Medication non-adherence (1) |
| Medication reconciliation (1) | Medication regimen complexity (1) | medication safety (1) |
| medication-/drug-related problem (MRP/DRP) (1) | Medicinal plants (1) | Medicine (2) |
| medicine-use practices (1) | Meloxicam (1) | Memory (1) |
| Memory and learning. (1) | Mentha arvensis (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabomics (1) |
| metagenomic (1) | metformin (6) | metformin hydrochloride (1) |
| Methanol (1) | methanolic extract (1) | methocel (1) |
| method development (2) | method validation (3) | Methotrexate (1) |
| methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
| MetS (1) | Mevalonate (1) | Micro emulsion (2) |
| Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
| Microbiological (1) | Microbroth dilution (1) | microcrystalline cellulose (3) |
| microdilution (1) | Microdosing (1) | microneedles (1) |
| Micronucleus assay (1) | microparticles (1) | microsphere (1) |
| microspheres (6) | microtriches (1) | Microwave-Assisted Extraction (1) |
| miglitol (1) | Migraine (2) | migraine management, (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) |
| mismatches (1) | mitochondria (1) | Mix mode (1) |
| MMAS-8 - Modified Morisky Adherence Scale-8 (1) | modern medicine (1) | modified melt dispersion technique (1) |
| Mol inspiration (1) | Molecular characterization (1) | Molecular docking (3) |
| Molecular mimicry (1) | monoamine oxidase B (1) | Monocots (1) |
| montelukast (2) | montelukast sodium (1) | Montelukast, (1) |
| moraceae (1) | Morin and validation (1) | Moringa oleifera (2) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Mortality (2) |
| Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) | MPTP (1) |
| MTT Assay (2) | MTT method (1) | MUC2 (1) |
| MUC6 (1) | Mucoadhesive (1) | Mucoadhesive agent (1) |
| mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) |
| mucodhesive (1) | multi granules (1) | multidrug resistant pathogens (1) |
| multiparticulates (1) | multiparticulates dosage form (1) | multiple regression (1) |
| multiple regression analysis (1) | Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) |
| Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (1) | Mycophenolic acid (1) |
| myocardial infarction (1) | Myomectomy. (1) | Myrica esculenta (1) |
| N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) | NABP (1) |
| Naftopidil (1) | nano size (1) | Nanoformulation (1) |
| Nanonization. (1) | Nanopacticle (1) | Nanoparticle (1) |
| Nanoparticles (6) | Nanosuspension (1) | Nanosuspension tablets (1) |
| Nanosuspensions (1) | Naphthoquinone derivative (1) | NAPLEX (1) |
| naproxen (1) | Naranjo (1) | Naranjo algorithm (1) |
| Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) | Narikel Lavan (1) |
| Nasal gel (1) | Nateglinide (1) | National Fomulary (1) |
| National Formulary (2) | National Public Health Programs (1) | natural compounds (2) |
| natural products (2) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (1) |
| nebivolol hydrochloride (1) | Necrosis. (1) | need assessment (1) |
| Nephroprotective (2) | Nephrotoxicity (1) | Nerium indicum (1) |
| neuropathy (1) | Neurosurgical (1) | neutropenia (1) |
| nevirapine (1) | new molecule (1) | Nicorandil (1) |
| Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
| nigrostriatal pathway (1) | Nil (5) | Nill (18) |
| niosome (1) | Niosomes (1) | Nitric acid (1) |
| NMDA (1) | NMDA receptors (1) | Nodular skin lesions (1) |
| Non-linear (1) | nonamers. (1) | noncommunicable disease (1) |
| noncompliance (1) | Nonionic surfactants (1) | nootropic (1) |
| Norfloxacin (1) | Normoglycemic rats (1) | northeast India (1) |
| Nose to brain delivery (1) | Nothopanax scutellarium (1) | Nuclear medicine (1) |
| nuclear pharmacy (1) | Nucleo CMP (1) | Nude mice (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (1) |
| Occupational health (1) | Ocimum gratissimum (1) | Off-label (1) |
| offending drugs (1) | Okra Mucilage (1) | Olmesartan (1) |
| olmesartan medoxomil (1) | Omeprazole. (1) | Omics (1) |
| Oncology. (1) | ondansetron (2) | ondansetron hydrochloride (1) |
| OPD – Outpatient Department. (1) | open field (1) | ophthalmic delivery (1) |
| ophthalmic inserts (1) | Opportunities (1) | Optimal stress (1) |
| optimization (7) | Oral cancer (1) | oral disintegrating tablets (1) |
| Oral glucose tolerance (1) | oral glucose tolerance test (3) | oral insulin (1) |
| Oral Rehabilitation (1) | organic acids (1) | organogel (1) |
| Origanum vulgare (1) | Original Article (3) | Originator. (1) |
| Orlistat (1) | orodispersible tablet (1) | orodispersible tablets (2) |
| Osmotic pump (1) | Osteoblast (2) | Osteoclast (1) |
| OTC switch (1) | Outdoor patients (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | OVX (1) |
| oxazepinone (1) | oxcarbazepine (1) | oxidative damage (1) |
| oxidative stress (6) | oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) |
| P-drug. (1) | P-drugs (1) | P-glycoprotein (1) |
| P. dulce (Fabaceae) (1) | p53 tumor suppressor gene (1) | Package insert (1) |
| Paediatric (2) | Pain (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| PAR-2 receptor (1) | para-diaminobenzaldehyde (1) | paracetamol (2) |
| Paracetamol. (1) | partial least square (1) | particle size analysis (1) |
| PASS (1) | passive avoidance learning (1) | patents (2) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| patient counseling (1) | patient education (1) | Patient health questionnaire (PHQ) (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (2) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (1) | Pediculosis (1) |
| PEGylation (1) | Penang (1) | penetration (1) |
| penetration enhancer (1) | penetration pressure (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L.) Kunth (2) | Peppas and Higuchi’s equations (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | percentage healing of wound area (1) |
| perception (3) | Periauricular tags. (1) | pericyclic fiber (1) |
| Periodontal disease (1) | periodontal diseases (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permeation (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
| Personal care products (2) | pH dependent approach (1) | pH independence (1) |
| pH-sensitive (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (1) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Marketing (1) | Pharmaceutical Services (1) | Pharmaceutical-Care (1) |
| Pharmaceutical-industries (1) | Pharmacist (4) | Pharmacist intervention. (1) |
| pharmacist role in public health (1) | Pharmacists (1) | pharmacists India (1) |
| Pharmacodynamic (1) | Pharmacodynamic activity (1) | pharmacodynamics (2) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | pharmacognostic standardization (1) |
| pharmacognostical (1) | pharmacognosy study (2) | Pharmacokinetic (2) |
| Pharmacokinetic interactions. (1) | pharmacokinetics (7) | Pharmacokinetics. (2) |
| Pharmacological properties (1) | Pharmacovigilance (10) | Pharmacovigilance Programme of India (1) |
| Pharmacovigilance. (1) | Pharmacovigilante’s (1) | pharmacy (4) |
| pharmacy curriculum (2) | Pharmacy education (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Phase I studies (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | phenolic compounds (2) |
| phenolics (1) | phenols (1) | Phenothiazine (1) |
| Phenytoin cold cream (1) | Pheritima posthuma (1) | Phleboliths (1) |
| Phoenix dactylifera (1) | Phosphorylase kinase (1) | Photoprotection. (2) |
| Phthalates (1) | Phyllanthus emblica, (1) | Phylogenetic tree (1) |
| Physical fitness (1) | Physichochemical Characterization (1) | Physicians (3) |
| physicochemical evaluation (1) | physicochemical properties (1) | physiochemical descriptor (1) |
| Phytochemical (2) | phytochemical prospection (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperine (1) | Piroxicam (1) | Pits and Fissures (1) |
| Pixel intensity. (1) | Plackett-Burman (1) | Plackett-Burman design (1) |
| plant extracts (1) | plasma (2) | Plasma concentration (1) |
| plasma concentrations (1) | Plasma creatinine (1) | Plasma urea (1) |
| plasma-brain correlation (1) | Plasma. (1) | Plasmodium falciparum 3D7 (1) |
| Plasmodium falciparum. (1) | Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) |
| PLGA (1) | PLSR (1) | Pluronic F 127 (1) |
| Pneumonia (1) | Poisoning pattern (1) | Polarography (1) |
| Poloxamer 188 (1) | Poloxamer 407 (2) | poly (lactic-co-glycolic acid) (1) |
| poly(ε-caprolactone) (1) | polycaprolactone (1) | Polycystic Ovary Syndrome (1) |
| Polyelectrolyte complex (PEC) (1) | PolyElectrolytecomplex (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymeric nanoparticles (1) | polypharmacy (3) |
| polypharmacy in diabetes mellitus. (1) | polyphenols (1) | Polysaccharide (1) |
| polyvinyl alcohol (2) | polyvinyl pyrrolidone (1) | porosity (1) |
| Positive and Negative stressors (1) | Positive coping strategies. (1) | Posology (1) |
| Possible mechanisms (1) | Potassium (1) | Potassium Channel (1) |
| Potassium chloride (1) | Potassium Nitrate (1) | PPAR agonists (1) |
| pPharmacokinetics (1) | practice (2) | practices (1) |
| pravastatin (1) | Pre ADMET (1) | pre prandial (1) |
| Pre University students (1) | Pre-authorization (1) | Precipitation (1) |
| precise (1) | Precision (1) | Pregnancy (1) |
| preliminary screening (2) | Premna esculenta (1) | prescriber (1) |
| Prescribing (1) | Prescribing errors (1) | Prescription (3) |
| Prescription error. (1) | prescription monitoring (1) | prescription only medicines (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (3) |
| Primary health care (2) | Primary Health Care. (1) | Principal component analysis (1) |
| principal component regression (1) | Private Medical College (1) | PRO (1) |
| Probiotic (1) | Probiotics (1) | process capability (1) |
| Process parameters. (1) | Products with Antimicrobial Action. (1) | progesterone (1) |
| Proniosomal gel (1) | propolis (1) | Proportional reporting ratio (1) |
| propranol hydrochloride (1) | Propranolol hydrochloride (1) | Prospective Study (1) |
| prostaglandins (1) | Proteasome activity (1) | protein proÞ le (1) |
| proteolytic enzymes (1) | Proton Pump Inhibitor (2) | Proton-pump Inhibitors (1) |
| Prteomics (1) | Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) |
| Psidium Guajava (1) | Psychological mindedness (1) | Psychomotor (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Publication (1) | Publications (2) | Pulmonary Fibrosis (1) |
| pulmonary hypertension (1) | Punica granatum (1) | pyrazine (1) |
| pyrazoline (1) | pyrazolines (1) | Q1F (1) |
| QOL (1) | QSAR (2) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality Control (1) | quality of internet information (1) |
| quality of life (2) | quantitative structure-activity relationship (1) | Quercetin (2) |
| quinazolin-4(3H)one (1) | quinazolinone (1) | Quinazolinone. (1) |
| quinoline derivatives (1) | R2 values (1) | Rabbits. (1) |
| radical scavenger (1) | radicals (1) | radiopharmaceuticals (1) |
| radiopharmacy (1) | Radioprotective (1) | Raillietina echinobothrida (1) |
| raloxifene hydrochloride (1) | Raman spectroscopy (1) | ramipril (2) |
| ranitidine (1) | Ranitidine hydrochloride (2) | Ranitidine’. (1) |
| ranolazine (1) | Ransmission electron microscopy (1) | Rapid disintegration (1) |
| Rasagiline mesylate (1) | Rat (1) | ratio test procedures (1) |
| Rational pharmacotherapy. (1) | Rational prescribing (1) | Rational use of medicine (1) |
| rational use of medicines (1) | rats (1) | re-precipitation (1) |
| recognized standards (1) | recovery studies (1) | Red ginger (1) |
| reforms (1) | Regression analysis (1) | Regressions statistics (1) |
| Regulations (1) | regulatory (2) | Regulatory affairs (1) |
| regulatory system (1) | Relative performance (1) | release kinetics (3) |
| Release studies. (1) | relese kinetics (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (2) | Response Surface Methodology (1) |
| Retention. (1) | reversed-phase chromatography (1) | rhizomes (1) |
| Riboflavin (1) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | rivastigmine (1) | RNAi (1) |
| RNAi technology (1) | RNTCP (1) | root (1) |
| Root canal infection (1) | Ropinirole (1) | rosuvastatin (1) |
| rosuvastatin calcium (1) | Royal Malaysian Custom Officer (1) | RP-HPLC (5) |
| RP-TLC/Densitometry (1) | rupatadine (1) | rutin (1) |
| ß avonoids (2) | S. mutans (1) | S.salivarius (1) |
| S.sanguis (1) | Saccharin (1) | Safe handling guidelines (1) |
| Safety (1) | saponins (1) | Sappan wood (1) |
| Saraschandra (1) | Saudi Arabia (1) | scanning electron microscopy (3) |
| Scientific Advertisements (1) | Scientometrics (3) | sclerotherapy (1) |
| Scores. (1) | Se- DeM ODT Expert system (1) | Secondary Level (1) |
| seizure outcome (1) | Selected area electron diffraction (1) | Self medication (1) |
| self-emulsifying drug delivery system (1) | self-medication (3) | self-nanoemulsification (1) |
| senna spectabilis (1) | sensory cortical activity. (1) | separation (1) |
| sepbox (1) | Sequential optimization (1) | Serum triglyceride (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | Signal detection. (1) |
| silymarin (1) | similarity factor (f2) (2) | simplex lattice (1) |
| Simplex Lattice Design (1) | simultaneous determination (2) | simultaneous extraction (1) |
| simvastatin (1) | simvastatin. (1) | Single nucleotide polymorphism (1) |
| sintering (1) | siRNA (1) | siRNA. (2) |
| six sigma (1) | SJS (1) | SLS (1) |
| Smix. (1) | Smoking (1) | smoking cessation. (1) |
| Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
| SNEDDS (2) | sobatum (1) | Social Media (1) |
| Social sexual. (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (1) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Solanum trilobatum (1) | Solanum xanthocarpum, (1) |
| solid dispersion (4) | solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) |
| solubility (5) | Solubility enhancement (1) | Solubility. (1) |
| solvent casting (1) | solvent evaporation (3) | sonication time (1) |
| sonophoresis (1) | spasmolytic (1) | speciÞ city (1) |
| Spectrometric (1) | spectrophotometry (2) | sperm count (1) |
| Spiro compounds (1) | Spleen colony assay (1) | sponge implantation assay (1) |
| sponsors (1) | Spontaneous-Reporting. (1) | Sprague Dawley (1) |
| spray drying (1) | stability (1) | stability indicating (1) |
| stability indicating and validation. (1) | Stability indicating assay (1) | Stability indicating assay method (1) |
| stability indicating method of artemether (1) | Stability of the physical properties (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (5) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statistical Modeling (1) | Statistical optimization (1) | Stem bark extract (1) |
| Stephania hernandifolia (1) | Stereospermum suaveolens (1) | Stereospermum tetragonum (2) |
| Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) | Stimulantia (1) |
| Streptococcus mutans (2) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | streptozotocin-induced diabetes (1) | Streptozotocin. (1) |
| stress (3) | stress studies (2) | structural descriptor (1) |
| Structured Communication. (1) | Stryphnodendron rotundifolium (1) | students (2) |
| students’ residence (1) | Sub Clinical Hypothyroidism. (1) | sublingual films (1) |
| substituted acetophenones (1) | sucrase (1) | Sudan (1) |
| Sulfonylurea (2) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunscreens. (1) | Super disintegrants (1) |
| superdisintegrants (2) | Superdisintergrants (1) | Superoxide Dismutase. (1) |
| superoxidedismutase (1) | superporous hydrogel composite (1) | support staff. (1) |
| Surface properties (1) | surfactant (1) | surfactants (1) |
| surgical prophylaxis. (1) | Surgical. (1) | Survey questionnaire (1) |
| Survival rate (1) | sustained release (3) | sustained release pellets (1) |
| sustained release. (1) | swelling index (1) | swelling studies (1) |
| Synchronous spectrofluorimetry. (1) | Synthesis (1) | Systematic Review. (1) |
| Tablet Compression (1) | Tactile stimulation (1) | tail suspension test (1) |
| Tamarindus indica (1) | Tamilians (1) | Tamoxifen (1) |
| Targeted drug delivery system (1) | taste masking (2) | tasteless complex (1) |
| taxane (1) | Taxus baccata (1) | Teaching Hospital (1) |
| Technology (1) | technology-enhanced learning (1) | tegument (1) |
| telmisartan (1) | TEN (1) | Tenofovir disoproxil fumarate (1) |
| Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | terpenoids (1) |
| Tertiary care hospital (1) | testicular damage (1) | testosterone (2) |
| Tetrapreniltoluquinone (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
| therapeutic drug monitoring (1) | therapeutic effectiveness (1) | Thermoreversible gel (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | time dependent approach (1) |
| Time lag (1) | Timed release (1) | Tobacco (1) |
| Tobacco smoking (1) | tolbutamide (1) | Tolerance (1) |
| Tooth brush. (1) | Toothpaste. (1) | Topical. (1) |
| Total flavonoid (1) | Total phenolic (1) | total quality management (1) |
| toxicity (1) | Toxicity. (2) | traditional medicine (2) |
| tramadol HCL (1) | Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) |
| Transcriptomics. (1) | transdermal (2) | transfer latency (1) |
| Transmucosal (1) | Transmucosal patch (1) | Treatment adherence. (1) |
| Treatment outcomes (1) | Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) |
| Tricyclic antidepressants (TCA) (1) | Triglycerides (1) | Trigonella foenum graecum (1) |
| Trigonelline (1) | Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) |
| Triphala (1) | triple distilled water (1) | Triterpenoid. (1) |
| Triterpenoids (1) | Triticum aestivum. (1) | Tropaeolum majus L (1) |
| tropicamide (1) | Trypsin (1) | Tuberculosis (1) |
| Tumor response (1) | Tween 80. (1) | Twisted (1) |
| Tylophora indica (1) | Tylophorinidine. (1) | type 2 diabetes (2) |
| type 2 diabetes. (1) | UACR (1) | UCPMP Guidelines (1) |
| ultrasonication-solvent evaporation technique (1) | Uncemented (1) | Underutilization of insulin. (1) |
| Unethical practices. (1) | Unique device identification (1) | Universities (1) |
| Unlicensed. (1) | Unnecessary use. (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (1) | Urinary Hydrogen Peroxide (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (1) |
| UV-spectrophotometry (2) | vada (1) | vaginal gel (1) |
| validation (13) | Valium (1) | Valproate (1) |
| valsartan (1) | Vanillin (1) | Vanillosmopsis arborea. (1) |
| vascular bundle (1) | vascular permeability (2) | vascular progenitors (1) |
| VED analysis (2) | VED analysis. (1) | Venography and Hemangioma (1) |
| Venous malformations (VMs) (1) | verapamil (3) | Verapamil HCl (1) |
| Vincristine. (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
| Visual analogue scale. (1) | Vitamin D deficiency (1) | Vitamin D. (1) |
| vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) |
| Vitex agnus Castus (1) | Voltage–gated calcium channels (1) | warfarin (2) |
| Water hyacinth (1) | web-based learning (1) | Weibull parameters (1) |
| wet granulation (1) | wetting time (1) | Wheat (1) |
| WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) | Wistar rats. (1) |
| Withania somnifera. (1) | Withdrawal (1) | Women. (1) |
| Work protection (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Yucca gloriosa L. (1) | Zero order release (1) | zero order spectrophotometry (1) |
| zeta potential (1) | zidovudine (1) | Zika virus (1) |
| Zingiberaceae (1) | zopiclone (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (2) | α-glucosidase (1) | β Amyloid1-42 (1) |
| β-carboline (1) | β-carotene production (1) | β-cyclodextrin (2) |
| ε-amino groups (1) | | |
